Article PDF
References
Roth, J.A. et al. Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med. 2, 985–991 (1996).
Flaman, J.M. et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. USA 92, 3963–3967 (1995).
Tada, M. et al. Clonality and stability of the p53 gene in human astrocytic tumor cells — quantitative analysis of p53 gene mutations by yeast functional assay. Int. J. Cancer 67, 447–450 (1996).
Temin, H.M. Evolution of cancer genes as a mutation-driven process. Cancer Res. 48, 1697–1701 (1988).
Flaman, J.M. et al. A rapid PCR fidelity assay. Nucleic Acids Res. 22, 3259–3260 (1994).
Finlay, C.A., Hinds, P.W. & Levine, A.J. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57, 1083–1093 (1989).
Dittmer, D. et al. Gain of function mutations in p53 . Nature Genet. 4, 42–45 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roth, J. Reply to “Retrovirus–mediated p53 gene therapy”. Nat Med 2, 1163 (1996). https://doi.org/10.1038/nm1196-1163b
Issue date:
DOI: https://doi.org/10.1038/nm1196-1163b
